This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
UK Drugs of Abuse Testing Market 2014: Hospitals and Commercial Labs is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 260 pages and 10 tables
SIMILAR MARKET STUDIES
Notes: Sales, means the sales volume of High-performance Liquid Chromatography (HPLC) Systems Revenue, means the sales value of High-performance Liquid Chromatography (HPLC) Systems This report studies sales (consumption) of High-performance Liquid Chromatography (HPLC) Systems in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these ...
February 2017 | $3900 | View Details >>
Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400. “2015-2019 Future Horizons and Growth Strategies in the US Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; ...
September 2015 | $6400 | View Details >>
2017 Colombia Republic Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales ...
January 2017 | $0 | View Details >>
Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 297-page report from VPGMarketResearch contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and ...
September 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research